# Gala Treatment for Chronic Bronchitis in Canada

> **NCT03385616** · NA · COMPLETED · sponsor: **Gala Therapeutics, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Chronic Bronchitis
- COPD

## Interventions

- **DEVICE:** Gala Airway Treatment System

## Key facts

- **NCT ID:** NCT03385616
- **Lead sponsor:** Gala Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-24
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-02-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03385616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03385616, "Gala Treatment for Chronic Bronchitis in Canada". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03385616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*